Resveratrol: Its Path from Isolation to Therapeutic Action in Eye Diseases

Overview

Journal Antioxidants (Basel)

Date 2022 Dec 23

PMID 36552655

Authors

Roxana Pop

Adela Daescu

Dumitrita Rugina

Adela Pintea

Affiliations

Soon will be listed here.

Abstract

Due to the confirmed therapeutic potential of resveratrol (Rv) for eye diseases, namely its powerful anti-angiogenic and antioxidant effects, this molecule must be studied more deeply. Nowadays, the pharmaceutic and pharmacokinetic available studies offer a troubling picture because of its low stability and bioavailability. To overcome this problem, researchers started to design and create different delivery systems that could improve the delivery amount of Rv. Therefore, this review aims to shed light on the proper and efficient techniques to isolate, purify and quantify the Rv molecule, and how this therapeutic molecule can be a part of a delivery system. The Rv great impact on aspects regarding its stability, bioavailability and absorption are also debated here, based on the existent literature on in vitro and in vivo human and animal studies. Moreover, after its absorption the Rv influence at the molecular level in ocular pathologies is described. In addition, the present review summarizes the available literature about Rv, hoping that Rv will gain more attention to investigate its unexplored side.

Citing Articles

Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques.

Pratsinis H, Mavrogonatou E, Zervou S, Triantis T, Hiskia A, Kletsas D Methods Mol Biol. 2025; 2906:315-359.

PMID: 40082365 DOI: 10.1007/978-1-0716-4426-3_19.

Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis.

Datseris I, Rouvas A, Tzanidaki M, Kardara M, Geros V, Gouliopoulos N Clin Ophthalmol. 2025; 19:217-225.

PMID: 39867345 PMC: 11762261. DOI: 10.2147/OPTH.S494595.

Synthesis and Evaluation of Glucosyl-, Acyl- and Silyl- Resveratrol Derivatives as Retinoprotective Agents: Piceid Octanoate Notably Delays Photoreceptor Degeneration in a Retinitis Pigmentosa Mouse Model.

Valdes-Sanchez L, Moshtaghion S, Caballano-Infantes E, Penalver P, Rodriguez-Ruiz R, Gonzalez-Alfonso J Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598393 PMC: 11597447. DOI: 10.3390/ph17111482.

Formulating Resveratrol and Melatonin Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Ocular Administration Using Design of Experiments.

Zingale E, Bonaccorso A, DAmico A, Lombardo R, DAgata V, Rautio J Pharmaceutics. 2024; 16(1).

PMID: 38258134 PMC: 10819881. DOI: 10.3390/pharmaceutics16010125.

One-year outcomes of resveratrol supplement with aflibercept versus aflibercept monotherapy in wet age-related macular degeneration.

Datseris I, Bouratzis N, Kotronis C, Datseris I, Tzanidaki M, Rouvas A Int J Ophthalmol. 2023; 16(9):1496-1502.

PMID: 37724273 PMC: 10475632. DOI: 10.18240/ijo.2023.09.17.

References

Zortea K, Franco V, Francesconi L, Cereser K, Lobato M, Belmonte-de-Abreu P . Resveratrol Supplementation in Schizophrenia Patients: A Randomized Clinical Trial Evaluating Serum Glucose and Cardiovascular Risk Factors. Nutrients. 2016; 8(2):73. PMC: 4772037. DOI: 10.3390/nu8020073. View

Ciaffi M, Paolacci A, Paolocci M, Alicandri E, Bigini V, Badiani M . Transcriptional regulation of stilbene synthases in grapevine germplasm differentially susceptible to downy mildew. BMC Plant Biol. 2019; 19(1):404. PMC: 6744718. DOI: 10.1186/s12870-019-2014-5. View

Stoia D, Pop R, Campu A, Nistor M, Astilean S, Pintea A . Hybrid polymeric therapeutic microcarriers for thermoplasmonic-triggered release of resveratrol. Colloids Surf B Biointerfaces. 2022; 220:112915. DOI: 10.1016/j.colsurfb.2022.112915. View

Sarkar A, Jayesh Sodha S, Junnuthula V, Kolimi P, Dyawanapelly S . Novel and investigational therapies for wet and dry age-related macular degeneration. Drug Discov Today. 2022; 27(8):2322-2332. DOI: 10.1016/j.drudis.2022.04.013. View

Ghadiri Soufi F, Mohammad-nejad D, Ahmadieh H . Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway. Pharmacol Rep. 2013; 64(6):1505-14. DOI: 10.1016/s1734-1140(12)70948-9. View

Lin Y, Chang H, Chen T, Chang J, Chiu W, Lin J . Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells. J Nutr. 2010; 140(12):2187-92. DOI: 10.3945/jn.110.123505. View

Tapeinos C, Battaglini M, Ciofani G . Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. J Control Release. 2017; 264:306-332. PMC: 6701993. DOI: 10.1016/j.jconrel.2017.08.033. View

Vaz-da-Silva M, Loureiro A, Falcao A, Nunes T, Rocha J, Fernandes-Lopes C . Effect of food on the pharmacokinetic profile of trans-resveratrol. Int J Clin Pharmacol Ther. 2008; 46(11):564-70. DOI: 10.5414/cpp46564. View

Fu J, Wang M, Guo H, Tian Y, Zhang Z, Song R . Profiling of components of rhizoma et radix polygoni cuspidati by high-performance liquid chromatography with ultraviolet diode-array detector and ion trap/time-of-flight mass spectrometric detection. Pharmacogn Mag. 2015; 11(43):486-501. PMC: 4522834. DOI: 10.4103/0973-1296.160455. View

10.

Nonomura S, Kanagawa H, Makimoto A . [CHEMICAL CONSTITUENTS OF POLYGONACEOUS PLANTS. I. STUDIES ON THE COMPONENTS OF KO-J O-KON. (POLYGONUM CUSPIDATUM SIEB. ET ZUCC.)]. Yakugaku Zasshi. 1963; 83:988-90. View

11.

Rossi M, Caruso F, Antonioletti R, Viglianti A, Traversi G, Leone S . Scavenging of hydroxyl radical by resveratrol and related natural stilbenes after hydrogen peroxide attack on DNA. Chem Biol Interact. 2013; 206(2):175-85. DOI: 10.1016/j.cbi.2013.09.013. View

12.

He S, Yan X . From resveratrol to its derivatives: new sources of natural antioxidant. Curr Med Chem. 2012; 20(8):1005-17. View

13.

Zupancic S, Lavric Z, Kristl J . Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. Eur J Pharm Biopharm. 2015; 93:196-204. DOI: 10.1016/j.ejpb.2015.04.002. View

14.

Buosi F, Alaimo A, Di Santo M, Elias F, Linares G, Acebedo S . Resveratrol encapsulation in high molecular weight chitosan-based nanogels for applications in ocular treatments: Impact on human ARPE-19 culture cells. Int J Biol Macromol. 2020; 165(Pt A):804-821. DOI: 10.1016/j.ijbiomac.2020.09.234. View

15.

Urpi-Sarda M, Zamora-Ros R, Lamuela-Raventos R, Cherubini A, Jauregui O, de la Torre R . HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans. Clin Chem. 2006; 53(2):292-9. DOI: 10.1373/clinchem.2006.071936. View

16.

Verheul H, Hoekman K, Eekman C, Folman C, Broxterman H, Pinedo H . Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res. 1998; 3(12 Pt 1):2187-90. View

17.

Calderon G, Juarez O, Hernandez G, Punzo S, De la Cruz Z . Oxidative stress and diabetic retinopathy: development and treatment. Eye (Lond). 2017; 31(8):1122-1130. PMC: 5558229. DOI: 10.1038/eye.2017.64. View

18.

Zafar S, Sachdeva M, Frankfort B, Channa R . Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies. Curr Diab Rep. 2019; 19(4):17. PMC: 7192364. DOI: 10.1007/s11892-019-1134-5. View

19.

Stewart M . Aflibercept (VEGF-TRAP): the next anti-VEGF drug. Inflamm Allergy Drug Targets. 2011; 10(6):497-508. DOI: 10.2174/187152811798104872. View

20.

Samec D, Karalija E, Sola I, Vujcic Bok V, Salopek-Sondi B . The Role of Polyphenols in Abiotic Stress Response: The Influence of Molecular Structure. Plants (Basel). 2021; 10(1). PMC: 7827553. DOI: 10.3390/plants10010118. View